11.25
전일 마감가:
$11.66
열려 있는:
$11.71
하루 거래량:
6.97M
Relative Volume:
1.57
시가총액:
$5.56B
수익:
$4.45B
순이익/손실:
$205.00M
주가수익비율:
28.12
EPS:
0.4
순현금흐름:
$372.00M
1주 성능:
-2.34%
1개월 성능:
-3.85%
6개월 성능:
-20.10%
1년 성능:
-29.95%
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
2500 INNOVATION WAY, GREENFIELD
ELAN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ELAN
Elanco Animal Health Inc
|
11.25 | 5.56B | 4.45B | 205.00M | 372.00M | 0.40 |
![]()
ZTS
Zoetis Inc
|
157.52 | 71.07B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
HLN
Haleon Plc Adr
|
9.71 | 43.91B | 14.26B | 1.55B | 0 | 0.3383 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
13.54 | 42.93B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.25 | 18.41B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
127.82 | 13.58B | 612.78M | -86.37M | -62.91M | -0.87 |
엘란코 Stock (ELAN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-09 | 개시 | UBS | Buy |
2024-12-02 | 개시 | Leerink Partners | Market Perform |
2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
2023-12-19 | 개시 | Jefferies | Buy |
2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
2022-07-12 | 개시 | Piper Sandler | Neutral |
2021-11-18 | 개시 | Morgan Stanley | Overweight |
2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
2021-08-05 | 재개 | Credit Suisse | Outperform |
2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
2021-04-15 | 개시 | Stifel | Buy |
2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2020-08-13 | 재개 | Credit Suisse | Neutral |
2020-08-04 | 재개 | Goldman | Buy |
2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2020-01-10 | 개시 | Raymond James | Mkt Perform |
2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2019-09-23 | 개시 | Barclays | Overweight |
2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
2019-05-23 | 개시 | Guggenheim | Neutral |
2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
2019-02-12 | 개시 | William Blair | Mkt Perform |
2019-01-23 | 개시 | UBS | Sell |
2019-01-15 | 개시 | Argus | Buy |
2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Elanco Animal Health (NYSE:ELAN) Hits New 52-Week LowTime to Sell? - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Purchased by Van ECK Associates Corp - MarketBeat
Elanco Animal Health (NYSE:ELAN) Shares Down 6.4%Time to Sell? - MarketBeat
Equitable Trust Co. Acquires Shares of 125,807 Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Poultry Vaccine & Drug Market Booming as Demand for Disease Prevention Increases - GlobeNewswire Inc.
Elanco stock touches 52-week low at $11.11 amid market challenges - Investing.com
Elanco receives FDA warning letter over Zenrelia marketing (ELAN:NYSE) - Seeking Alpha
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
Veterinary Oncology Market Detailed In New Research Report 2025 - openPR
Elanco Reinforces Commitment to Veterinary and Pet Owner Education - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
Veterinary Medicine Market Growth, Demand, Industry Size & - openPR
(ELAN)Analyzing Elanco Animal Health's Short Interest - Benzinga
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Veterinary Infectious Diseases Therapeutics Market Share - openPR
Private Management Group Inc. Grows Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect - Markets Insider
Animal Doctor: Concerns about several veterinary drug products - Washington Times Herald
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Caprock Group LLC - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation - yourbigsky.com
Veterinary Eye Care Market to Grow by USD 1.05 Billion(2024-2028), Boosted by Rising Pet Ownership & Market Transformation Driven by AITechnavio - The Malaysian Reserve
Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation - Markets Insider
Veterinary Wound Cleansers Market Share & Growth Forecast Report 2025-2030, with Elanco, Vetoquinol, Virbac, Innovacyn, Axio Biosolutions, Neogen, Pet Natural Remedies, Zoetis and More - Yahoo Finance
India’s Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc. - Yahoo Finance
Animal Parasiticides Market Witness Growth: Size, Share, - openPR
Elanco Launches Pradalex for Treatment of Livestock Respiratory Diseases - Drovers Magazine
BlackRock, Inc.'s Strategic Acquisition of Elanco Animal Health Inc Shares - GuruFocus.com
Elanco launches novel treatment for livestock respiratory diseases - Feedstuffs
Pet Pharmaceuticals Market Growth to Accelerate in Forecast - openPR
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Acquired by KBC Group NV - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Reach Out - yourbigsky.com
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2024 Financial Results Announcement - Financial Times
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Connect - Markets Insider
Jim Cramer on Elanco Animal Health Incorporated (ELAN): ‘Not My Favorite’ - Yahoo Finance
Elanco Animal Health (NYSE:ELAN) Given New $14.00 Price Target at Morgan Stanley - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Meet the Faces of Zen: Elanco’s Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal - 3BL Media
Elanco Animal demitasse Health Incorporated - The Branding Iron
Veterinary Medicine Market Is Booming Worldwide 2025-2032 | - openPR
Elanco price target lowered to $14 from $15 at Morgan Stanley - MSN
2025-01-29 | Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Shareholders to Inquire about Securities Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing
ELAN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Elanco Animal Health Incorporated and Urges Investors to Contact the Firm Today! - ACCESS Newswire
Investors Who Lost Money With Elanco Animal Health Incorporated (NYSE:ELAN) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit - ACCESS Newswire
Meet the Faces of Zen: Elanco's Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal - Quantisnow
ELAN FRAUD NOTICE: Lose Money on Your Elanco Investment? BFA Law is Investigating the Company for Securities Fraud and Urges You to Contact the Firm (NYSE:ELAN) - ACCESS Newswire
2025-01-26 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect | NYSE:ELAN | Press Release - Stockhouse Publishing
ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):